Department of Pharmacy, Seoul National University Hospital, Seoul, Korea.
Korean J Intern Med. 2011 Mar;26(1):28-33. doi: 10.3904/kjim.2011.26.1.28. Epub 2011 Mar 2.
BACKGROUND/AIMS: The Compliance Questionnaire-Rheumatology (CQR) is a validated scale to evaluate patient compliance for anti-rheumatic medications. We developed a Korean version of the CQR (KCQR) and confirmed its reliability and validity.
We prepared the KCQR by translating and back-translating the original CQR with modifications to adapt it to Korean culture. Fifty Korean patients with rheumatoid arthritis (RA) were enrolled in this study. The test-retest reliability of the KCQR was evaluated at a 2-week interval using the intraclass correlation coefficient (ICC). The validity of the KCQR was assessed by identifying associations between KCQR scores and patient compliance, measured using pharmacy refill data.
The reliability of the KCQR was adequate, with an ICC of 0.71 for test-retest reliability. With respect to validity, the summed score of the weighted KCQR showed a significant correlation with pharmacy refill data (r² = 0.57) on multiple regression analysis.
Our results indicate that the KCQR is a reliable, valid instrument to evaluate compliance of Korean patients for RA medications.
背景/目的：《顺应性问卷-风湿病学》（CQR）是一种经过验证的评估抗风湿药物患者顺应性的量表。我们开发了 CQR 的韩文版（KCQR），并证实了其可靠性和有效性。
我们通过翻译和回译原始 CQR 并进行修改以适应韩国文化来准备 KCQR。本研究纳入了 50 名韩国类风湿关节炎（RA）患者。使用组内相关系数（ICC）评估 KCQR 在 2 周间隔的重测信度。通过确定 KCQR 评分与使用药房补充数据测量的患者顺应性之间的关联来评估 KCQR 的有效性。
KCQR 的可靠性良好，重测信度的 ICC 为 0.71。关于有效性，加权 KCQR 的总和得分在多元回归分析中与药房补充数据（r²=0.57）显著相关。
我们的结果表明，KCQR 是一种可靠、有效的评估韩国 RA 药物患者顺应性的工具。
Zotero 插件
